ReNeuron Group Plc Share Price London S.E.
Equities
Biotechnology & Medical Research
Sales 2022 | 403K 503K 41.97M | Sales 2023 | 530K 662K 55.2M | Capitalization | 5.17M 6.46M 539M |
---|---|---|---|---|---|
Net income 2022 | -9M -11.24M -937M | Net income 2023 | -5M -6.25M -521M | EV / Sales 2022 | 8.48 x |
Net cash position 2022 | 13.99M 17.47M 1.46B | Net cash position 2023 | 6.73M 8.41M 701M | EV / Sales 2023 | -2.94 x |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-0.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 78.26% |
Latest transcript on ReNeuron Group Plc
Managers | Title | Age | Since |
---|---|---|---|
John Hawkins
DFI | Director of Finance/CFO | 58 | 01/14/01 |
Suzanne Hancock
COO | Chief Operating Officer | - | 01/17/01 |
Chief Tech/Sci/R&D Officer | - | 03/22/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Walton
BRD | Director/Board Member | 61 | 22/22/22 |
Iain Ross
CHM | Chairman | 71 | 01/21/01 |
Director/Board Member | 61 | 14/21/14 |
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |